SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
Beta Bionics Inc
Common Stock, $0.0001 par value per share (the "Shares") · CUSIP: 08659B102
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Zone Healthcare Holdings, LLC
Shares: 3,277,220 · Class: 7.5%
- Farallon Capital Partners, L.P.
Shares: 185,460 · Class: 0.4%
- Farallon Capital Institutional Partners, L.P.
Shares: 199,940 · Class: 0.5%
- Farallon Capital Institutional Partners II, L.P.
Shares: 70,718 · Class: 0.2%
- Farallon Capital Institutional Partners III, L.P.
Shares: 47,800 · Class: 0.1%
- Four Crossings Institutional Partners V, L.P.
Shares: 46,974 · Class: 0.1%
- Farallon Capital Offshore Investors II, L.P.
Shares: 418,307 · Class: 1%
- Farallon Capital (AM) Investors, L.P.
Shares: 28,860 · Class: 0.1%
- Farallon Capital F5 Master I, L.P.
Shares: 38,641 · Class: 0.1%
- Farallon Capital Management, L.L.C.
Shares: 3,277,220 · Class: 7.5%
- Farallon Partners, L.L.C.
Shares: 998,059 · Class: 2.3%
- Farallon F5 (GP), L.L.C.
Shares: 38,641 · Class: 0.1%
- Farallon Institutional (GP) V, L.L.C.
Shares: 46,974 · Class: 0.1%
- Dapice Joshua J.
Shares: 4,313,920 · Class: 9.9%
- Dreyfuss, Philip D.
Shares: 4,313,920 · Class: 9.9%
- Dunn Hannah E.
Shares: 4,313,920 · Class: 9.9%
- Fried, Richard B
Shares: 4,313,920 · Class: 9.9%
- Gehani, Varun N.
Shares: 4,313,920 · Class: 9.9%
- Giauque, Nicolas
Shares: 4,313,920 · Class: 9.9%
- Kim, David T.
Shares: 4,313,920 · Class: 9.9%
- Linn, Michael G.
Shares: 4,313,920 · Class: 9.9%
- Luo Patrick (Cheng)
Shares: 4,313,920 · Class: 9.9%
- Patel, Rajiv A.
Shares: 4,313,920 · Class: 9.9%
- Roberts, Jr., Thomas G.
Shares: 4,313,920 · Class: 9.9%
- Saito Edric C.
Shares: 4,313,920 · Class: 9.9%
- Seybold, William
Shares: 4,313,920 · Class: 9.9%
- Short Daniel S.
Shares: 4,313,920 · Class: 9.9%
- Spokes, Andrew J. M.
Shares: 4,313,920 · Class: 9.9%
- Warren, John R.
Shares: 4,313,920 · Class: 9.9%
- Wehrly, Mark C.
Shares: 4,313,920 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-25-000330
- Form type
- SCHEDULE 13G/A
- Filer
- Beta Bionics, Inc.
- CIK
- CIK 1674632
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership